Marzoog Basheer Abdullah
World-Class Research Center, Digital Biodesign and Personalized Healthcare, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Oman J Ophthalmol. 2024 Feb 21;17(1):4-10. doi: 10.4103/ojo.ojo_237_22. eCollection 2024 Jan-Apr.
Coronavirus infection disease-19 (COVID-19) is a worldwide catastrophic emergency that first appeared in late 2019, in Wuhan, China. COVID-19 is a multitropism disease that first affects lung tissue. However, extrapulmonary manifestations have been suspected from the first COVID-19 cases. The ocular signs and symptoms were from the early changes that occur during the course of the disease. Changes in the anterior eye segment have a relatively higher incidence than the posterior eye segment. Of which, conjunctivitis, COVID-19 pharyngioceratoconjuctivitis, iridocyclitis, corneal punctate epitheliopathy, and pathomorphological changes in the physio-anatomy of the anterior eye segment. The potential pathogenesis includes direct penetration of the virus into the eye (conjunctiva, lumbus, and cornea) or due to a systemic pathway through viremia, as well as due to autoimmune antibodies against the ocular structure (immune privilege). The presence of ocular manifestations of the external anterior fibrous layer suggests a mild course of the disease.
冠状病毒感染疾病-19(COVID-19)是一场全球灾难性紧急事件,于2019年末在中国武汉首次出现。COVID-19是一种多嗜性疾病,最初影响肺组织。然而,从首例COVID-19病例起就有人怀疑其存在肺外表现。眼部体征和症状源于疾病过程中早期出现的变化。眼前节的变化发生率相对高于眼后节。其中包括结膜炎、COVID-19咽结膜角膜炎、虹膜睫状体炎、角膜点状上皮病变以及眼前节生理解剖结构的病理形态学变化。潜在发病机制包括病毒直接侵入眼睛(结膜、泪囊和角膜)或通过病毒血症的全身途径,以及针对眼部结构的自身免疫抗体(免疫赦免)。眼前部纤维层出现眼部表现提示疾病进程较轻。